Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?

Posted
By integrating digitization and machine learning, there is an opportunity to deliver personalized care to all patients and scale precision dosing with minimal physician involvement, maximizing the effectiveness and accessibility of these drugs. The post Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution? appeared first on MedCity News.

Continue reading at MedCity News »

BioPharma, Daily, MedCity Influencers, Opinion, Pharma, Physicians, adherence, biopharma nl, GLP-1 drugs, machine learning, Personalized Medicine, side effects